Moreover, bradykinin is also known to interact with EGFR and stimulate downstream signaling pathways to enhance cell invasion as well as promote angiogenesis through elevated VEGF expression in glioma (66, 67). This evidence concerns the gene VEGFA and central nervous system cancer.